发明名称 |
USE OF RECOMBINANT HUMAN UTEROGLOBIN IN TREATMENT OF INFLAMMATORY AND FIBROTIC CONDITIONS |
摘要 |
Compositions and methods for preventing or treating primary cancer cell growth and tumor metastasis, as well as stimulation of hematopoiesis are described and claimed. The present invention also relates to methods of treating cancer and uteroglobin receptor-related conditions by targeting a uteroglobin receptor with recombinant human uteroglobin (rhUG). Also disclosed and claimed are methods of purifying a uteroglobin receptor and methods of using such receptor(s) to identify uteroglobin structural analogs and UG-receptor ligands.
|
申请公布号 |
WO0004863(A2) |
申请公布日期 |
2000.02.03 |
申请号 |
WO1999US16312 |
申请日期 |
1999.07.19 |
申请人 |
CLARAGEN, INC.;NATIONAL INSTITUTES OF HEALTH |
发明人 |
PILON, APRILE;MUKHERJEE, ANIL, B.;ZHANG, ZHONGJIAN |
分类号 |
G01N33/50;A61K38/00;A61K38/17;A61P11/00;A61P13/12;A61P27/00;A61P29/00;A61P31/00;A61P35/00;A61P37/02;A61P43/00;C07K14/46;C07K14/47;C07K16/18;C07K17/00;G01N33/15;G01N33/53;G01N33/566;(IPC1-7):A61K/ |
主分类号 |
G01N33/50 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|